2934 logo

J Frontier Co.,Ltd. Stock Price

TSE:2934 Community·JP¥9.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2934 Share Price Performance

JP¥1,747.00
262.00 (17.64%)
JP¥1,747.00
262.00 (17.64%)
Price JP¥1,747.00

2934 Community Narratives

There are no narratives available yet.

Recent 2934 News & Updates

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Aug 25
Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

J Frontier Co.,Ltd. Key Details

JP¥21.5b

Revenue

JP¥11.9b

Cost of Revenue

JP¥9.6b

Gross Profit

JP¥9.5b

Other Expenses

JP¥87.0m

Earnings

Last Reported Earnings
May 31, 2025
Next Reporting Earnings
Oct 15, 2025
Earnings per share (EPS)
16.33
Gross Margin
44.52%
Net Profit Margin
0.40%
Debt/Equity Ratio
214.5%

J Frontier Co.,Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Acceptable track record with mediocre balance sheet.

3 Risks
2 Rewards

About 2934

Founded
2008
Employees
202
CEO
Atsuhiro Nakamura
WebsiteView website
jfrontier.jp

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Japanese Market Performance

  • 7 Days: -1.8%
  • 3 Months: 10.3%
  • 1 Year: 15.3%
  • Year to Date: 13.5%
Over the last 7 days, the market has dropped 1.8%, driven by declines in the Consumer Discretionary and Financials sectors of 3.6% and 4.0%, respectively. As for the longer term, the market has actually risen by 15% in the last year. Earnings are forecast to grow by 8.2% annually. Market details ›